The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ROCKET-CLL: A randomized, open-label, multicenter, phase 3 study of rocbrutinib (LP-168) versus pirtobrutinib in covalent BTK inhibitor (cBTKi) in pretreated relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
 
Anna Chen
Employment - Newave Pharmaceutical
Stock and Other Ownership Interests - Newave Pharmaceutical
Travel, Accommodations, Expenses - Newave Pharmaceutical
 
Jennifer Woyach
Consulting or Advisory Role - Abbvie; AstraZeneca; Beigene; Genentech; Janssen; Loxo; Merck; Newave Pharmaceutical; Pharmacyclics
Research Funding - Abbvie (Inst); beone (Inst); Janssen; Loxo/Lilly (Inst); Merck (Inst); Schrodinger
 
John Seymour
Honoraria - Abbvie; AstraZeneca; BeiGene; BMS; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; BMS; Genor BioPharma; Gilead Sciences; Janssen; Roche; TG Therapeutics
Speakers' Bureau - Abbvie; AstraZeneca; Roche
Research Funding - Abbvie; Celgene; Janssen; Loxo/Lilly; Roche
Patents, Royalties, Other Intellectual Property - named patent holder for venetolcax dose ramp up and combination treatment. I do not receive any royalties
Expert Testimony - Roche; TG Therapeutics
Travel, Accommodations, Expenses - Abbvie; Roche
 
Danielle Brander
Honoraria - BeiGene; Lilly; Nurix; Pharmacyclics
Consulting or Advisory Role - BMS; Lilly; Nurix
Research Funding - Abbvie (Inst); ArQule (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Carna Biosciences (Inst); Catapult Therapeutics (Inst); Genentech (Inst); MEI Pharma (Inst); Newave Pharmaceutical (Inst); Novartis (Inst); Nurix; Pharmacyclics (Inst)
 
Deborah Stephens
Honoraria - BeiGene; Ipsen
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; BeiGene; BMS; Celgene; Genentech; Janssen; Lilly; Pharmacyclics
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Celgene (Inst); Genentech (Inst); Novartis (Inst)
 
Neil Kay
Consulting or Advisory Role - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); AstraZeneca (Inst); BeiGene (Inst); DAAN Biotherapeutics (Inst); DAVA Oncology (Inst); Janssen Biotech (Inst); Merck (Inst); Pharmacyclics (Inst); Vincerx Pharma (Inst)
Research Funding - Abbvie; Acerta Pharma; Bristol-Myers Squibb; Celgene; Vincerx Pharma (Inst)
 
Fenlai Tan
Employment - Newave pharmaceutical Inc
Leadership - Newave pharmaceutical Inc
Stock and Other Ownership Interests - Newave pharmaceutical Inc
Honoraria - Newave pharmaceutical Inc
Patents, Royalties, Other Intellectual Property - Newave pharmaceutical Inc
Travel, Accommodations, Expenses - Newave pharmaceutical Inc
 
Yi Chen
Employment - Newave pharmaceutical Inc
Leadership - Newave pharmaceutical Inc
Stock and Other Ownership Interests - Newave pharmaceutical Inc
Patents, Royalties, Other Intellectual Property - Newave pharmaceutical Inc
Travel, Accommodations, Expenses - Newave pharmaceutical Inc
 
Stephen Anthony
Employment - Newave Pharmaceutical
Leadership - Newave Pharmaceutical
Stock and Other Ownership Interests - Biolexis Therapeutics; Newave Pharmaceutical
Consulting or Advisory Role - Biolexis Therapeutics
Travel, Accommodations, Expenses - Biolexis Therapeutics
 
Kewei Shang
Employment - Newave pharmaceutical Inc
 
Yue Shen
Employment - Lupeng pharmaceutical Inc
Leadership - Lupeng pharmaceutical Inc
 
Yejiang Lou
Employment - Guangzhou Lupeng pharmaceutical CO.LTD
 
John Byrd
Stock and Other Ownership Interests - Eilean Pharma; Vincerx Pharma
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Eilean; Kartos Therapeutics; Newave Pharmaceutical; Ohio State Univ Drug Development Inst (Inst); Orange Grove Bio; Orbimed; Vincerx Pharma
Research Funding - Eilean Pharma (Inst); Newave Pharmaceutical (Inst); Orange Grove Bio (Inst); Orbimed
Patents, Royalties, Other Intellectual Property - OSU Patents
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Novartis; Pharmacyclics; TG Therapeutics